Study to Evaluate the Safety of Combinations of Avelumab, Binimetinib and Talazoparib in Patients With Advanced Cancer
A Phase 1B/2 Study to Evaluate Safety and Clinical Activity of Combinations of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or
Metastatic RAS-Mutant Solid Tumors
Category & Conditions: Cancer
Medicine: BAVENCIO(AVELUMAB)
MEKTOVI® TABLETS(BINIMETINIB)
Talzenna (talazoparib)
ClinicalTrials.gov Identifier (NCT): NCT03637491
Protocol ID: B9991033
PrintDownloadOpen Plain Language Summary Result: Click here